Medicaid spending on antiretrovirals nearly tripled in recent years

Medicaid spending on antiretrovirals nearly tripled between 2007 and 2019 because of increased antiretroviral use, as well as higher prices, according to a recent study.
“We performed this study because antiretroviral medications to treat HIV remain a major source of Medicaid drug spending decades after these drugs were first introduced,” Benjamin N. Rome, MD, MPH, associate physician at the Harvard Medical School’s division of general internal medicine and primary care and a faculty member of the division of pharmacoepidemiology and pharmacoeconomics, told Healio.
Rome and

Medicaid spending on antiretrovirals nearly tripled between 2007 and 2019 because of increased antiretroviral use, as well as higher prices, according to a recent study.
“We performed this study because antiretroviral medications to treat HIV remain a major source of Medicaid drug spending decades after these drugs were first introduced,” Benjamin N. Rome, MD, MPH, associate physician at the Harvard Medical School’s division of general internal medicine and primary care and a faculty member of the division of pharmacoepidemiology and pharmacoeconomics, told Healio.
Rome and